Kibow Changes Name of Flagship Kidney Function Support Product to ‘RENADYL™’

     

    NEWTOWN SQUARE, Pa., Nov. 8, 2011 — Kibow Biotech, Inc. (a suburban Philadelphia-based Company) announced today, at the occasion of Renal Week, it is changing the brand name of its flagship product to “RENADYL™.” Formerly known as Kibow® Biotics, this patented and clinically t…

    (Read More...) 247 views

    Kibow Biotech, Inc. Secures $2.4 Million Towards Its Human Clinical Trials by Continued Veterinary Licensing Agreement

     

    NEWTOWN SQUARE, Pa., Aug. 24, 2011 — Kibow Biotech, Inc. today announced that it has renewed its exclusive worldwide licensing and marketing agreement with the current licensing partner specializing in animal health. The agreement concerns “Azodyl™,” a patented, 100% natura…

    (Read More...) 292 views

    Institutional Review Board Approval Obtained for Study of Kibow(R) Biotics in Dialysis Patients with End-stage Chronic Kidney Disease

     

    PHILADELPHIA, March 10, 2011 — On the occasion of World Kidney Day, Kibow Biotech, Inc. is pleased to announce its renewed commitment, hope and support for the worldwide maintenance of healthy kidney function among all those people with kidney problems.
    In addition, Kibow Biotech, Inc. would al…

    (Read More...) 300 views

    Fresenius Medical Care, N.A. Has Selected VitalRemedyMD’s VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients

     

    VitalProteinRx is a state-of-the-art medical food designed to provide highly concentrated quality protein specifically for patients on dialysis and those with diabetes
    BOCA RATON, Fla., Oct. 9, 2009 — VitalRemedyMD, a physician-established company, offers scientifically formulated int…

    (Read More...) 804 views